Searched for
RUSSIA S GAMALEYA INSTITUTE
Omicron variant could replace Delta strain globally: Head of Russian Gamaleya InstituteAccording to the Gamaleya institute director, the effectiveness of the Russian Sputnik V vaccine against the Omicron strain will be tested ...- Sputnik Light produces strong level of antibodies against COVID-19 in early-stage trialsThe vaccine, a single-dose version of the two-dose Sputnik V vaccine unveiled last year, has already entered later phases of studies and is...
- Gap between Sputnik V COVID-19 shots can be up to 180 days - Russia's RDIFAn official at the RDIF, which markets the vaccine abroad, made the comments in a statement after some countries decided to widen the gap b...
- More delays in Delhi-NCR's 'Sputnik V' COVID-19 vaccine rolloutSputnik V uses two different viruses that cause the common cold (adenovirus) in humans. The two doses, given 21 days apart, are different a...
- Sputnik V COVID-19 vaccine roll out delayed in DelhiFortis Healthcare, which had said it would make Sputnik V available at its Gurgaon and Mohali hospitals from Saturday, also has not started...
- Serum Institute gets DCGI's nod to manufacture Sputnik V in India for test, analysis"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and anal...
- Russia says Sputnik V vaccine does not cause blood clots"A comprehensive analysis of adverse events during clinical trials and over the course of mass vaccinations with the Sputnik V vaccine show...
- Russia to try out 'Sputnik-Light' COVID vaccine to make it go furtherAccording to authorities, over a million Russians have so far been inoculated with the original two-dose version of Sputnik V, named after ...
- AstraZeneca to test combining COVID-19 vaccine with Russian shotThe developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.
- Russia approves second coronavirus vaccine after early trialsThe peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested among 100 volunteers in earl...
- India’s coronavirus vaccine pipeline could be one of the largest in the world“Nationally, nearly 30 Covid-19 vaccine candidates are under development, by both industry and academia. These vaccines are in different st...
- Russia looking for partnership with India for producing COVID-19 vaccine Sputnik: RDIF CEOSputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not ...
- Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
- Russia starts production of coronavirus vaccine, shows reportRussia has said the vaccine, developed by Moscow's Gamaleya Institute and the first for the coronavirus to go into production, will be roll...
- Indian pharma producers show great interest in Covid-19 vaccine Sputnik V: Russian sovereign wealth fundThe RDIF has funded research and production of Sputnik V, the world’s first approved coronavirus vaccine, developed by the Moscow-based Gam...
- Russia not world's first to develop coronavirus vaccine: Kiran Mazumdar-ShawThe world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairp...
- Russia plans to register the world's first coronavirus vaccine on August 12"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...
- Russia aims to launch mass production of coronavirus vaccine doses by 2021The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stag...
- Russia plans mass vaccination against coronavirus from October, health workers first in lineA source told Reuters this week that Russia's first potential COVID-19 vaccine, developed by a state research facility, would secure local ...
- Search for solution: Russia plans to register first coronavirus vaccine by August 12The drug developed by Moscow’s Gamaleya Institute and the Russian Direct Investment Fund may be approved for civilian use within three to s...
Load More
